Abstract

Osteons are the repeating unit throughout cortical bone, consisting of canals filled with blood and nerve vessels surrounded by concentric lamella of hydroxyapatite-containing collagen fibers, providing mechanical strength. Creating a biodegradable scaffold that mimics the osteon structure is crucial for optimizing cellular infiltration and ultimately the replacement of the scaffold with native cortical bone. In this study, a modified air-gap electrospinning setup was exploited to continuously wrap highly aligned polycaprolactone polymer nanofibers around individual 1393 bioactive glass microfibers, resulting in a synthetic structure similar to osteons. By varying the parameters of the device, scaffolds with polymer fibers wrapped at angles between 5–20° to the glass fiber were chosen. The scaffold indicated increased cell migration by demonstrating unidirectional cell orientation along the fibers, similar to recent work regarding aligned nerve and muscle regeneration. The wrapping decreased the porosity from 90% to 80%, which was sufficient for glass conversion through ion exchange validated by inductively coupled plasma. Scaffold degradation was not cytotoxic. Encapsulating the glass with polymer nanofibers caused viscoelastic deformation during three-point bending, preventing typical brittle glass fracture, while maintaining cell migration. This scaffold design structurally mimics the osteon, with the intent to replace its material compositions for better regeneration.

Highlights

  • Around 1.6 million people require bone grafts annually in the U.S for degenerative diseases, injuries, tumors, and infections, accounting for approximately USD 244 billion [1,2]

  • Bone grafts are currently used when this bone injury is larger than what the natural bone healing process can mend, which is termed a critical size bone defect

  • The current gold standard for critical size bone defects involve the use of autologous bone grafts, but donor and receiving sites potentially experience pain, complications, limited donor bone volume, and increased risks of infection [4,5,6,7]

Read more

Summary

Introduction

Around 1.6 million people require bone grafts annually in the U.S for degenerative diseases, injuries, tumors, and infections, accounting for approximately USD 244 billion [1,2]. The current gold standard for critical size bone defects involve the use of autologous bone grafts, but donor and receiving sites potentially experience pain, complications, limited donor bone volume, and increased risks of infection [4,5,6,7]. These current methods are lacking, whether it is due to the addition of an invasive surgery inducing another fracture, or risks immune rejection from another donor. There has been a rise in interest over the last decade to create bone substitutes that mimic and replace the native bone

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call